Mutation analysis in the BRCA2 gene in primary breast cancers

Nature Genetics

Volumn 13, Issue 2, 1996, Pages 245-247

  Miki, Yoshio ^a   Katagiri, Toyomasa ^a   Kasumi, Fujio ^b   Yoshimoto, Takamasa ^b   Nakamura, Yusuke ^a,c  

^a The Japan Foundation   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; FRAMESHIFT MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MISSENSE MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0030058209     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0696-245     Document Type: Article

References (22)

1. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
2. Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 (1991).
3. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250, 1233-1238(1990).
4. Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1763(1995).
5. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792(1995).
6. Tavtigian, S.V. et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet. 12, 333-337(1996).
7. Matera, A.G., Hellmann, U. & Schmid, C.W. A Transpositionally and transcriptionally competent Alu subfamily. Mol. Cell. Biol. 10, 5424-5432(1990).
8. Batzer, M.A. & Deininger, P.L. A human-specific subfamily of Alu sequence. Genomics 9, 481-487(1991).
9. Deininger, P.L., Jolly, D.J., Rubin, C.M., Friedman, T. & Schmid, C. W. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J. Mol. Biol. 151, 17-23(1981).
10. Rogers, J. Retroposons defined. Nature 301, 460 (1983).
11. Deininger, P.L. Mobile DNA, (eds Berg, D.E. & Howe, M.M.) 619-636 (Am. Soc. Microbiol., Washington, 1989).
12. Vidaud, D. et al. Haemophilia B due to a de novo insertion of a human-specific AIu subfamily member within the coding region of the factor IX gene. Eur. J. Hum. Genet. 1, 30-36(1993).
13. Muratani, K. et al. Inactivation of the cholinesterase gene by Alu insertion : possible mechanism for human gene transposition. Proc. Natl. Acad. Sci. USA 88, 11315-11319(1991).
14. Mitchell, G.A. et al. Splice-mediated insertion of an Alu sequence inactivates ornithine δ-aminotransferase : A role for Alu elements in human mutation. Proc. Natl. Acad. Sci. USA 88, 815-819(1991).
15. Wallace, M.R., Andersen, L.B., Saulino, A.M., Gregory, P.E., Glover, T.W. & Collins, F.S. A de novo Alu insertion results in neurofibromatosis type 1. Nature 353, 864-866(1991).
16. Dombroski, B.A., Mathias, S.L., Nanthakumar, E., Scott, A. & Kazazian, H.H., Jr. Isolation of an active human transposable element. Science. 254, 1805-1808(1991).
17. Miki, Y. et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643-645(1992).
18. Holt, J.T. et al. Growth retardation and tumour inhibition by BRCA1. Nature Genet. 12, 298-302 (1996).
19. Jensen, R.A. et al. BRCA1 is secreted and exhibits properties of a granin. Nature Genet. 12, 303-308(1996).
20. Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L & Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444-450 (1995).
21. Chomczynski, P.A. Reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Bio Techniques 15, 532-536(1993).
22. Koyama, K., Sudo, K. & Nakamura, Y. Isolation of 115 human chromosome 8 specific expressed sequence tags by exon amplification. Genomics 26, 245-253(1995).